医学
重症监护医学
医疗保健
肺
疾病
临床实习
囊性纤维化
人工智能应用
多样性(控制论)
肺病
病人护理
特发性肺纤维化
决策支持系统
梅德林
患者数据
临床研究
医疗保健系统
医疗
卫生技术
精密医学
罕见病
临床诊断
医学物理学
人工智能
最佳实践
临床治疗
个性化医疗
出处
期刊:PubMed
[National Institutes of Health]
日期:2026-01-12
卷期号:49 (1): 78-83
标识
DOI:10.3760/cma.j.cn112147-20250728-00445
摘要
Rare lung diseases are a group of diseases characterized by significant clinical heterogeneity, challenging diagnosis and treatment processes, and diverse underlying causes. Due to their uncommon symptoms and limited awareness among healthcare providers, these diseases are frequently misdiagnosed or diagnosed too late, resulting in poor patient outcomes and placing a significant healthcare burden on the healthcare system. However, in recent years, the rapid advancements in artificial intelligence (AI) technology within the medical field have created new opportunities for early identification, accurate diagnosis, and personalized management of these diseases. A variety of AI techniques, ranging from traditional machine learning to more recent methods such as deep learning, reinforcement learning, and transfer learning, have been employed in areas such as clinical decision support, radiomics, omics data analysis, and the prediction of treatment responses for rare lung diseases. This article systematically reviews the latest research progress of AI applications in idiopathic pulmonary fibrosis, cystic fibrosis, idiopathic pulmonary arterial hypertension, and other rare lung diseases. It also emphasizes AI's potential benefits in disease classification, treatment evaluation, and prognosis prediction through illustrative research examples.
科研通智能强力驱动
Strongly Powered by AbleSci AI